This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
The Health and Human Services Office of Inspector General has found that, in a few cases, FDA officials veered from the accelerated approval pathway.
The Food and Drug Administration’s approval of low-risk tobacco pouches is welcome, but why did it delay for more than four ...
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
WASHINGTON: Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and ...
Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...
Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation in pain relief in more than two decades.
Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...
People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.
Joel Stanley, the founder and former CEO of Charlotte’s Web, is leading an effort to achieve approval from the FDA for a novel treatment to treat autism spectrum ...
The decision builds on previous FDA approval for the drug’s treatment when combined ... Spravato’s approval through its Priority Review process after receiving results from a randomized ...
A Food and Drug Administration project to promote diversity in clinical studies of cancer treatments was removed from the ...